{{Rsnum
|rsid=2970848
|Gene=PPARGC1A
|Chromosome=4
|position=23815404
|Orientation=plus
|GMAF=0.3806
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=PPARGC1A
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 54.9 | 38.1 | 7.1
| HCB | 52.2 | 39.7 | 8.1
| JPT | 61.9 | 35.4 | 2.7
| YRI | 23.3 | 47.9 | 28.8
| ASW | 21.1 | 52.6 | 26.3
| CHB | 52.2 | 39.7 | 8.1
| CHD | 54.6 | 41.7 | 3.7
| GIH | 43.6 | 45.5 | 10.9
| LWK | 28.2 | 53.6 | 18.2
| MEX | 22.4 | 39.7 | 37.9
| MKK | 33.3 | 47.4 | 19.2
| TSI | 55.9 | 34.3 | 9.8
| HapMapRevision=28
}}{{PMID Auto
|PMID=21595954
|Title=Association of PGC-1alpha polymorphisms with age of onset and risk of Parkinson's disease
|OA=1
}}

{{PMID|19200361|OA=1
}} PGC-1alpha as modifier of onset age in Huntington disease.

{{PMID|21211002|OA=1
}} Localization of sequence variations in PGC-1alpha influence their modifying effect in Huntington disease.

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}